Goldman Sachs downgrades Brazilian equities to Neutral on slowdown, earnings risk
Published 1 d ago4 sourcesEvidence: Reported
Brazilian health plan operators reported mixed Q3 results while hospital operators showed solid performance. Pharmacy and pharmacist demand for GLP-1 drugs continues to support a positive outlook, indicating sustained growth in the weight-loss drug market. The divergence between health plan and hospital performance suggests pricing pressure on insurers versus volume-driven hospital growth.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago4 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 23 h ago1 sourceEvidence: Unknown
Published 3 d ago1 sourceEvidence: Reported